Ocular Hypertension (OHT) Overview
Learn About Ocular Hypertension (OHT)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Miami
Felipe Medeiros is an Ophthalmologist in Miami, Florida. Dr. Medeiros is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Medeiros is currently accepting new patients.
Wills Eye Ophthalmology Clinic, Inc
Joel Schuman is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Schuman is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.
New York University
Joseph Panarelli is an Ophthalmologist in New York, New York. Dr. Panarelli is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy. Dr. Panarelli is currently accepting new patients.
Summary: This is a prospective, observational, multi-center and post-authorization safety study that includes patients with a diagnosis of Neovascular Glaucoma. The investigator will have made the decision to use Eylea for treatment. The objective of this study is to assess safety and effectiveness of Eylea using in real clinical practice. Patients will be followed for a time period of 6 months from start ...
Summary: The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are: * The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence p...